In July, the American Board of Internal Medicine (ABIM), a medical specialty board focused on establishing standards for physicians to achieve and maintain board certification, announced new appointments and model for its Specialty Board and Exam Committees.

The new governance model calls for the Specialty Boards—previously tasked almost exclusively with creating the exam in their discipline—to broaden their role and take on the work of defining and assessing the full scope of competencies in their discipline across the spectrum of ABIM’s Certification and Maintenance of Certification (MOC) programs.

For the first time, each of the Specialty Boards includes two public members, one a member of the inter-professional health care team, the other a person providing the patient/caregiver perspectives. In the new structure, each discipline will have a Specialty Board and a separate Exam Committee.

Each Specialty Board’s unique ideas about which assessments are valuable in their discipline will enable them to define, refine and set standards for their specific Certification and MOC program. They will also perform oversight and review of performance assessments in the discipline and continue to build partnerships with societies and other organizational stakeholders in support of ABIM work. Each Exam Committee will continue to work closely with their respective Specialty Board as they develop and set performance standards for Certification and MOC exams.

New members of the Specialty Boards and Exam Committees include faculty from BWH:

Shalender Bhasin, MD, director, BWH Research Program in Men’s Health: Aging and Metabolism of Research, will chair the Endocrinology, Diabetes, and Metabolism Board Exam Committee.

Ilene Galinsky, MSN, Dana-Farber Cancer Institute/BWH Adult Leukemia Program, will serve as a public member on the Medical Oncology Board.

Marie D. Gerhard-Herman, MD, Division of Cardiovascular Medicine, BWH Department of Medicine, will serve on the Cardiology Board Cardiovascular Disease Exam Committee.

Paul E. Sax, MD, clinical director, BWH Infectious Disease Clinic, will serve on the Infectious Disease Board Exam Committee.

Richard M. Stone, MD, clinical director, Dana-Farber Cancer Institute/BWH Adult Leukemia Program, will serve on the Medical Oncology Board.

Article adapted from an American Board of Internal Medicine press release.